There is no evidence to suggest that Toluidine Blue is a cost-effective method of picking up oral cancers in a primary care setting.
Given the large number of people that will have false positive rates for a first positive test and even a double positive test, the harm of using it in terms of anxiety could well outweigh the benefits in terms of additional cancers detected.